Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

LEUPROLIDE ACETATE Drug Profile

« Back to Dashboard

What is the patent landscape for Leuprolide Acetate, and when can generic versions of Leuprolide Acetate launch?

Leuprolide Acetate is a drug marketed by Genzyme, Sandoz, Teva Pharms Usa, and Sun Pharma Global. and is included in four NDAs.

The generic ingredient in LEUPROLIDE ACETATE is leuprolide acetate. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.

Summary for Tradename: LEUPROLIDE ACETATE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list38
Clinical Trials: see list469
Patent Applications: see list9,678
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEUPROLIDE ACETATE at DailyMed

Pharmacology for Tradename: LEUPROLIDE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme
LEUPROLIDE ACETATE
leuprolide acetate
INJECTABLE;INJECTION075721-001Nov 29, 2001DISCNNoNo► Subscribe► Subscribe
Sun Pharma Global
LEUPROLIDE ACETATE
leuprolide acetate
INJECTABLE;INJECTION078885-001Mar 9, 2009APRXNoNo► Subscribe► Subscribe
Sandoz
LEUPROLIDE ACETATE
leuprolide acetate
INJECTABLE;INJECTION074728-001Aug 4, 1998APRXNoYes► Subscribe► Subscribe
Teva Pharms Usa
LEUPROLIDE ACETATE
leuprolide acetate
INJECTABLE;INJECTION075471-001Oct 25, 2000APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot